By browsing this site you accept the site’s cookies, which provide us with data used to personalize our interactions with you. Accessing social networking sites from this site may also require the use of cookies. You may refuse, change, or learn more about your cookie settings in our Cookie Policy.

Esty Dwek
Head of Global Market Strategy, Dynamic Solutions
Natixis Investment Managers
Ms. Dwek has more than 12 years of experience in the financial industry. Before joining Natixis Investment Managers in 2016, she was a global strategist with the emerging markets team at Loomis, Sayles & Company, where her responsibilities included developing global macroeconomic and asset class views, as well as asset allocation ideas.
She began her investment industry career in 2006 at HSBC Private Bank where she worked in Geneva, New York and Singapore and spent her last six years there as an investment strategist in London.
As Head of Global Thematics & Macro Research, Ms Dwek is responsible for developing and communicating market research, macroeconomic views, investment ideas and asset allocation positioning, as well as long-term return assumptions. These views help inform investment decisions across Dynamic Solutions' portfolios.
Ms. Dwek holds a BA in Political Science from Princeton University.
2396960.1.3
Related Articles

Natixis Investment Managers Solutions latest thinking on what’s moving markets.

Macro specialist Esty Dwek looks at interest rates and inflation risk amid the Covid-19 vaccination effort and economic recovery.

As the Covid-19 recovery begins in earnest, our macro strategists discuss market conditions – including reopening opportunities and risks.

While the question of how high bond yields may rise is important, equity market fundamentals continue to look strong for the near term.
- Post-Pandemic Markets: Why Reflation May Not Equal Inflation
- Brexit and European Trade: What’s Been Accomplished – and What’s Next?
- The Big Allocation Move for Institutions in 2021: No Move at All
- 10 Potential Market Risks and Questions for 2021
- Vaccines Drive Optimism – But Are They Already Priced In?
- Beyond Covid: Better Times Ahead